Loading…
Standard BioTools Inc. (LAB) Price Prediction 2026–2050
Rank #3347NASDAQBearish
$0.9184
-2.07% (24h)
Standard BioTools Inc. (LAB) Forecast Summary
Standard BioTools Inc. is projected to rise to $1.05 by 2027, a +14% move from its current price of $0.9184. LAB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Healthcare
Live market data via Yahoo Finance · updated 7/12/2026
Market Cap
$359.52M
24h Volume
$96.23M
Shares Outstanding
391.46M LAB
All-Time High
$27.30
Green Days (30d)
14/30
Volatility (30d)
7.64%
Standard BioTools Inc. (LAB) Price Prediction Summary
LAB Short-Term Price Forecast
Next 7 days
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.8832 | $0.9196 | $0.9575 | +0.13% |
| Jul 14 | $0.8696 | $0.9208 | $0.9749 | +0.26% |
| Jul 15 | $0.8596 | $0.9219 | $0.9887 | +0.38% |
| Jul 16 | $0.8515 | $0.9231 | $1.00 | +0.51% |
| Jul 17 | $0.8445 | $0.9243 | $1.01 | +0.64% |
| Jul 18 | $0.8383 | $0.9255 | $1.02 | +0.77% |
| Jul 19 | $0.8328 | $0.9267 | $1.03 | +0.90% |
Next 7 weeks
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8328 | $0.9267 | $1.03 | +0.90% |
| Week 2 | $0.8039 | $0.935 | $1.09 | +1.81% |
| Week 3 | $0.784 | $0.9434 | $1.14 | +2.73% |
| Week 4 | $0.7688 | $0.9519 | $1.18 | +3.65% |
| Week 5 | $0.7564 | $0.9605 | $1.22 | +4.58% |
| Week 6 | $0.746 | $0.9691 | $1.26 | +5.53% |
| Week 7 | $0.7371 | $0.9779 | $1.30 | +6.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
What is Standard BioTools Inc. (LAB)?
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses.
The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc.
The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
Standard BioTools Inc. Price Prediction Overview
Standard BioTools Inc. (LAB) is a healthcare company. Its current price is $0.9378 and its market capitalization is $367.11M. Its rank is 3321, with historical extremes of all-time high $27.30 and all-time low $0.0742.
The forecast suggests an upside trajectory over the coming years, with 2026 averaging $0.9378 and 2030 averaging $1.26, rising further to an average of $3.10 by 2040 and $7.72 by 2050. The corresponding max prices rise to $2.03 in 2030, $6.08 in 2040, and $17.01 in 2050, indicating substantial long‑term upside potential.
LAB Market & Technical Analysis
LAB Key Price Levels
Strong Support−79.0%
$0.1931
A major floor 79.0% below — a decisive break under it would weaken the trend.
Current Support−20.5%
$0.73
The nearest floor, 20.5% below — buyers have tended to step in here.
Current Resistance+38.3%
$1.27
The nearest ceiling, 38.3% above — a clean break opens room to run.
Strong Resistance+560.1%
$6.06
A major ceiling 560.1% above — clearing it would confirm fresh momentum.
Key LAB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
LAB Market Analysis
Trend ConsensusMixed
Bullish share of indicators43%
Timeframe AlignmentSplit
Price above 6/12 moving averages50%
Risk AssessmentModerate
~77% annualised volatility64%
Momentum (RSI)Balanced
RSI 53 — buying vs selling pressure53%
A snapshot of LAB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
LAB Indicator Summary
Sell
Based on 26 indicators
- Buy
- 9
- Neutral
- 5
- Sell
- 12
Bearish43% BullishBullish
Indicators computed on daily closing prices.
Moving Averages
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.906 | Buy | $0.9043 | Buy |
| MA 10 | $0.861 | Buy | $0.8855 | Buy |
| MA 20 | $0.839 | Buy | $0.9967 | Sell |
| MA 50 | $2.21 | Sell | $1.40 | Sell |
| MA 100 | $1.43 | Sell | $1.36 | Sell |
| MA 200 | $0.7849 | Buy | $1.11 | Sell |
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.60 | Neutral |
| Stoch RSI (14) | 90.89 | Sell |
| CCI (20) | 94.74 | Neutral |
| Williams %R (14) | -9.52 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 16.46 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 90.48 | Sell |
| TRIX (15) | -3.41 | Sell |
| Awesome (5,34) | -0.22 | Sell |
| Ultimate (7,14,28) | 64.61 | Neutral |
| Momentum (10) | 0.18 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 0.93 | Sell |
| ADX (14) | 19.35 | Neutral |
| ATR (14) | 0.13 | Info |
Pivot Levels
- S3$0.1367
- S2$0.4333
- S1$0.6767
- Pivot$0.9733
- R1$1.22
- R2$1.51
- R3$1.76
The 30-day technical picture is neutral. RSI14 stands at 60, with the 50-day simple moving average at $0.9488 and the 200-day simple moving average at $1.17, suggesting prices are hovering around key moving averages. Nearby support is at $0.73 and resistance at $1.27, framing a relatively tight short‑term range.
Over the last 30 days, the price range moved from a low of $0.7137 to a high of $1.23, indicating limited volatility in the near term. The stock also exhibits high historical volatility, with an annualized volatility of 80%, which can amplify moves in either direction.
Standard BioTools Inc. (LAB) Price Prediction 2026–2050
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.73 | $0.9184 | $1.46 | 0% | Neutral | |
| $0.7956 | $1.05 | $1.47 | +14% | Neutral | |
| $0.8054 | $1.11 | $1.64 | +20% | Bullish | |
| $0.8633 | $1.23 | $1.90 | +34% | Bullish | |
| $0.8458 | $1.24 | $1.99 | +36% | Bullish | |
| $1.12 | $1.69 | $2.78 | +84% | Bullish | |
| $1.23 | $1.93 | $3.24 | +110% | Bullish | |
| $1.21 | $1.93 | $3.33 | +111% | Bullish | |
| $1.27 | $2.09 | $3.68 | +128% | Bullish | |
| $1.16 | $1.95 | $3.51 | +113% | Bullish | |
| $1.60 | $3.04 | $5.90 | +231% | Bullish | |
| $3.41 | $7.57 | $16.50 | +725% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
Standard BioTools Inc. (LAB) 2026 Monthly Forecast
Current Price $0.9184Range $0.73 – $1.460% ROI
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.73 | $0.9184 | $1.14 | +0.00% |
| August 2026 | $0.8432 | $1.01 | $1.25 | +9.76% |
| September 2026 | $0.8543 | $1.03 | $1.30 | +2.39% |
| October 2026 | $0.8476 | $1.03 | $1.32 | +0.12% |
| November 2026 | $0.8805 | $1.08 | $1.39 | +4.69% |
| December 2026 | $0.9055 | $1.12 | $1.46 | +3.58% |
Click any year to see its month-by-month LAB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Standard BioTools Inc. (LAB) Year-by-Year Price Prediction
Standard BioTools Inc. (LAB) Price Prediction 2026
Expect LAB to range from $0.73 to $1.46 through 2026. The $0.9184 average target implies a 0% move from current prices. Price action looks broadly range-bound.
Standard BioTools Inc. (LAB) Price Prediction 2027
The LAB price prediction for 2027 points to an average of $1.05 (low $0.7956, high $1.47) — a potential gain of +14% on today's $0.9184. A consolidation phase looks the most probable path here.
Standard BioTools Inc. (LAB) Price Prediction 2028
In 2028, LAB is projected to trade between $0.8054 and $1.64, averaging $1.11 — a potential gain of +20% from today's $0.9184. That is up +6% on the projected 2027 average. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2029
Standard BioTools Inc.'s 2029 outlook centres on $1.23, within a $0.8633 to $1.90 range. That is up +11% on the projected 2028 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
Standard BioTools Inc. (LAB) Price Prediction 2030
By 2030, LAB could reach as high as $1.99, with a base case around $1.24 and support toward $0.8458 — roughly +36% from $0.9184. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2031
Expect LAB to range from $1.12 to $2.78 through 2031. The $1.69 average target implies a +84% move from current prices. That is up +36% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Standard BioTools Inc. (LAB) Price Prediction 2032
The LAB price prediction for 2032 points to an average of $1.93 (low $1.23, high $3.24) — a potential gain of +110% on today's $0.9184. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2033
In 2033, LAB is projected to trade between $1.21 and $3.33, averaging $1.93 — a potential gain of +111% from today's $0.9184. That is up 0% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Standard BioTools Inc. (LAB) Price Prediction 2034
Standard BioTools Inc.'s 2034 outlook centres on $2.09, within a $1.27 to $3.68 range. That is up +8% on the projected 2033 average. That marks a +128% change versus current levels. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2035
By 2035, LAB could reach as high as $3.51, with a base case around $1.95 and support toward $1.16 — roughly +113% from $0.9184. Buyers look set to stay in control over this stretch.
Standard BioTools Inc. (LAB) Price Prediction 2040
Expect LAB to range from $1.60 to $5.90 through 2040. The $3.04 average target implies a +231% move from current prices. That is up +55% on the projected 2035 average. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2050
The LAB price prediction for 2050 points to an average of $7.57 (low $3.41, high $16.50) — a potential gain of +725% on today's $0.9184. Buyers look set to stay in control over this stretch.
Investment Calculator
Scenario
Investing $1,000 in LAB today (≈ 1,088.850174 LAB) could be worth
$8,246.41
+$7,246.41 (+725%) by 2050 · US Dollar
Based on the average projected LAB price of $7.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
LAB tools
If You Had Invested in Standard BioTools Inc.
See what a past investment in LABwould be worth at today's price.
Invested
$1,000 invested in LAB on Jul 10, 2025 (≈ 740.740728 LAB) would be worth
$680.3
-$319.7 (-32.0%) today · 0.68× · US Dollar
Based on a LAB entry price of $1.35 vs. today's $0.9184.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.91 | $1,009.23 | +0.9% |
| 1 month ago | $0.88 | $1,043.64 | +4.4% |
| 3 months ago | $0.503285 | $1,824.81 | +82.5% |
| 6 months ago | $0.1319 | $6,962.86 | +596.3% |
| 1 year ago | $1.35 | $680.3 | -32.0% |
| All time (5.0y) ago | $5.79 | $158.62 | -84.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Will LAB reach a target price?
Enter a price to see how it sits against our LAB forecast.
Likely(2.0× current price)
Our base-case forecast reaches $1.80 around 2032.
Implied market cap at $1.80: $704.63M
Standard BioTools Inc. Long-Term Forecast (2026–2050)
The multi‑year forecast paints a bullish path after 2027, with notable upside through 2030 and beyond. In 2026 the average is $0.9378, rising to $1.26 in 2030, and to $3.10 by 2040, then to $7.72 in 2050. The forecasted maximums rise from $2.03 in 2030 to $6.08 in 2040 and $17.01 in 2050, reflecting growing upside potential.
The yearly ROI figures illustrate a progression from 0 in 2026 to 13.4 in 2027, 20.4 in 2028, 33.5 in 2029, 34.4 in 2030, 84.8 in 2031, 109.8 in 2032 and 2033, 127.7 in 2034, 111 in 2035, 230.2 in 2040, and a striking 723 in 2050, underscoring broad upside along the horizon. Sentiment shifts to bullish from 2028 onward, highlighting growing confidence as the years progress. These are estimates, not guarantees, and should be considered in the context of broader market conditions and individual risk tolerance.
LAB Frequently Asked Questions
Tap a question to reveal the answer.
What will Standard BioTools LAB be worth in 2030?
2030 forecast: min $0.8502, avg $1.26, max $2.03, ROI 34.4; sentiment BULLISH.
Is LAB a good investment based on the forecast?
Forecasts show bullish sentiment from 2028 onward with an avg price of $1.26 in 2030 and $7.72 in 2050, along with increasing ROI values; these are estimates and not guarantees.
Can LAB reach $5 according to the forecast?
Yes. The 2040 max is $6.08 and the 2050 max is $17.01, while shorter horizon maxes include $2.03 in 2030; the trajectory suggests upside that could exceed $5 by 2040 or 2050.
What are LAB's all‑time high and all‑time low?
All‑time high $27.30; all‑time low $0.0742.
Standard BioTools Inc. Community Discussion
0Share your Standard BioTools Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.